Archive · 24 Sep 2025
Amit Kalyani Re-Appointed to Hikal Board Amidst Family Dispute
Amit Kalyani, part of the Kalyani family, is back on the board of Hikal, a pharmaceutical company.
This happened because shareholders, representing almost everyone, voted for him to return.
The vote took place at the company's yearly meeting.
This is interesting because the Kalyani and Hiremath families, who own big parts of the company, are arguing over who should be in charge.
Even though there's a family fight, the Hiremath family voted to keep things going smoothly for Hikal.
Two different groups that advise shareholders gave different opinions on whether to support him or not.
Amit Kalyani has been a director since 2012 but isn't involved in the daily running of the company.
Amit Kalyani was re-appointed to Hikal's board.
Shareholders supported his re-appointment with 99.59% of the vote.
The Hiremath family voted in favor despite a family dispute.
Amit Kalyani is a non-executive, non-independent director.
Conflicting recommendations were given by proxy advisory firms.
- Who
- Amit Kalyani
- What
- Re-appointed to the board of Hikal.
- When
- During the 37th annual general meeting.
- Where
- Hikal.
- Why
- Shareholders voted overwhelmingly in favor of his re-appointment.
Proxy Advisory Firm 1
Proxy Advisory Firm 2
Amit Kalyani's Re-appointment
Proxy Advisory Firm 1
Recommended shareholders vote against his re-appointment.
Proxy Advisory Firm 2
Advised support for the resolution.
- Company
- Hikal
- Amit Kalyani Role
- Non-executive, non-independent director
- Vote in Favor
- 99.59%
- Kalyani Family Stake
- 34%
- Hiremath Family Stake
- 35%
- Hikal Promoter Group Stake
- 68.85%